Sales outperformed a declining market, with strong execution in Europe and India and resilient margins. New product launches and bookings support a positive outlook, despite ongoing cost inflation and supply chain risks. A $200 million share repurchase and strategic supply agreements reinforce capital discipline.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.